Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

Uğur Şahin, Evelyna Derhovanessian, Matthias Miller et al. · Nature · 2017 · 2.5K citations

Medicine, Immunology, Oncology +14

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Katalin Karikó, Hiromi Muramatsu, Frank A. Welsh et al. · Molecular Therapy · 2008 · 1.9K citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

Lena M. Kranz, Mustafa Diken, Heinrich Haas et al. · Nature · 2016 · 1.7K citations

Life Sciences, Immunology, Oncology +17

Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020

Erin K. Stokes, Laura D. Zambrano, Kayla N. Anderson et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 1.6K citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +13

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J. M. Brouwer, Tom G. Caniels, Karlijn van der Straten et al. · Science · 2020 · 1.3K citations · Full text

Life Sciences, Immunology, Infectious Diseases +17